Third, we conclude that plasma exosomal CXCL12 may serve as an effective biomarker for PD, because previous studies have indicated that peripheral blood levels of CXCL12 correlate with pathological processes and disease progression in PD, making them potential diagnostic and prognostic markers [98,99]. This evidence concerns the gene CXCL12 and Parkinson disease.